ATW SPAC Management’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,746
Closed -$724 251
2023
Q1
$724 Hold
15,746
﹤0.01% 182
2022
Q4
$168 Hold
15,746
﹤0.01% 206
2022
Q3
$1K Hold
15,746
﹤0.01% 305
2022
Q2
$2K Hold
15,746
﹤0.01% 311
2022
Q1
$4 Buy
+15,746
New +$5.74K ﹤0.01% 286

ATW SPAC Management's IQMDW Position: Q2 2023 in Review

ATW SPAC Management sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 15,746 shares — an estimated $724 sold.

ATW SPAC Management first reported a position in IQMDW in Q1 2022 and held it in 5 quarters. The position peaked at $2K in Q2 2022. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

  • ATW SPAC Management reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
  • ATW SPAC Management sold 15,746 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $724.
  • ATW SPAC Management first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q1 2022 and held it in 5 quarters.
  • ATW SPAC Management's Intelligent Medicine Acquisition Corp. Warrant position peaked at $2K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on ATW SPAC Management's 13F filing for Q2 2023, filed 11 Aug 2023.